GramEye Inc. CEO Yu Hiraoka Speaks as Panelist at International Symposium "STS forum Japan – Thailand Symposium 2026"
NQ Score
88/100
N1 Content Completeness
90
AI Summary (NQ-processed)
GramEye Inc. CEO Yu Hiraoka participated as a panelist at the international symposium "STS forum Japan – Thailand Symposium 2026" held in Bangkok, Thailand, where he introduced the company's efforts to solve the Antimicrobial Resistance (AMR) problem using AI and robotics technology, and their medical device "Micrium®."